ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,449Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 2588

$1.11M Total Retail Price of All Prescriptions

Rank: 69 out of 2588

733 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 733 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

25% of this provider’s 733 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 16,968 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
HYDROCODONE-ACETAMINOPHEN 902 514 S3 1 7
FUROSEMIDE 678 473 2 5
LEVOTHYROXINE SODIUM 611 482 3 2
OMEPRAZOLE 566 445 4 6
LISINOPRIL 564 470 5 3
RANITIDINE HCL 540 391 6 37
SIMVASTATIN 526 431 7 1
METOPROLOL TARTRATE 463 400 8 9
WARFARIN SODIUM 443 377 9 10
AMLODIPINE BESYLATE 362 349 10 4
POTASSIUM CHLORIDE 342 255 11 15
METOPROLOL SUCCINATE 328 255 12 12
LOVASTATIN 308 261 13 34
CITALOPRAM HBR 305 240 14 27
GABAPENTIN 282 192 15 18
METFORMIN HCL 275 245 16 8
FENOFIBRATE 270 219 17 64
METFORMIN HCL ER 251 166 18 67
LISINOPRIL-HYDROCHLOROTHIAZIDE 247 214 19 35
TRAMADOL HCL 246 172 20 19
DONEPEZIL HCL 235 230 21 22
ATENOLOL 224 211 22 14
ATORVASTATIN CALCIUM 201 137 23 11
CLOPIDOGREL 192 169 24 30
CARVEDILOL 191 153 25 20
PANTOPRAZOLE SODIUM 186 173 26 28
HYDROCHLOROTHIAZIDE 182 152 27 13
AZITHROMYCIN 179 140 28 45
NEXIUM 178 130 29 41
CRESTOR 173 118 30 25
PREDNISONE 172 122 31 42
ALLOPURINOL 171 153 32 33
TAMSULOSIN HCL 169 140 33 23
ZOLPIDEM TARTRATE 162 135 34 24
CIPROFLOXACIN HCL 162 123 34 82
TORSEMIDE 147 89 36 133
SPIRIVA 145 125 37 56
MELOXICAM 138 128 38 51
ALENDRONATE SODIUM 132 61 39 21
FENTANYL 130 108 S2 40 78
LEVOFLOXACIN 125 103 41 77
DIOVAN 125 103 41 29
PROMETHAZINE HCL 124 74 R 43 180
NIFEDIPINE ER 123 115 44 59
TRIAMTERENE-HCTZ 123 117 44 46
PROAIR HFA 122 78 46 50
ENALAPRIL MALEATE 121 107 47 31
LOSARTAN POTASSIUM 117 98 48 17
LANTUS 115 74 49 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 114 74 50 127
GLIPIZIDE XL 114 114 50 140
PLAVIX 110 100 52 43
CYCLOBENZAPRINE HCL 109 53 R 53 87
CYMBALTA 105 20 54 70
SPIRONOLACTONE 105 74 54 58
ISOSORBIDE MONONITRATE ER 104 104 56 49
INSULIN SYRINGE 100 51 57 81
PRAVASTATIN SODIUM 100 92 57 16
SINGULAIR 98 68 59 94
ESTRADIOL 96 77 R 60 344
MECLIZINE HCL 95 77 61 120
CELEBREX 92 73 62 99
KLOR-CON 10 92 80 62 75
DIGOXIN 91 91 64 38
CARBIDOPA-LEVODOPA 88 88 65 83
RISPERIDONE 87 42 66 57
LANTUS SOLOSTAR 85 69 67 93
ESCITALOPRAM OXALATE 85 81 67 68
LYRICA 84 33 69 100
PAROXETINE HCL 83 64 70 71
DICYCLOMINE HCL 83 51 70 215
ADVAIR DISKUS 82 64 72 48
LANSOPRAZOLE 82 50 72 157
FELODIPINE ER 81 81 74 108
CHLORZOXAZONE 78 38 R 75 393
VERAPAMIL ER 78 70 75 102
QUETIAPINE FUMARATE 76 61 77 74
FLUCONAZOLE 76 35 77 277
CEFUROXIME 76 60 77 183
SERTRALINE HCL 76 47 77 26
PRAMIPEXOLE DIHYDROCHLORIDE 75 45 81 188
METHOTREXATE 74 64 82 190
FLUTICASONE PROPIONATE 72 69 83 40
CLONIDINE HCL 72 43 83 54
OXYBUTYNIN CHLORIDE 71 63 85 132
LOSARTAN-HYDROCHLOROTHIAZIDE 69 65 86 66
NAMENDA 69 69 86 32
PROPRANOLOL HCL 68 28 88 128
VESICARE 67 38 89 172
COMBIVENT 67 54 89 145
MORPHINE SULFATE ER 67 43 S2 89 204
DIPHENOXYLATE-ATROPINE 67 63 89 331
METOCLOPRAMIDE HCL 66 53 93 136
PHENYTOIN SODIUM EXTENDED 66 0 93 109
BENAZEPRIL HCL 66 56 93 84
FAMOTIDINE 66 12 93 36
BACLOFEN 64 11 97 142
NITROFURANTOIN MONO-MACRO 63 54 98 234
DIOVAN HCT 63 52 98 72
PEN NEEDLE 62 59 100 112
PREMARIN 62 50 R 100 247
SYNTHROID 61 61 102 88
GLIMEPIRIDE 61 45 102 39
GLIPIZIDE 60 32 104 44
JANUVIA 59 45 105 60
BENICAR HCT 58 46 106 187
KLOR-CON M20 57 33 107 52
WELCHOL 57 46 107 343
DIVALPROEX SODIUM 57 14 107 89
POLYETHYLENE GLYCOL 3350 56 46 110 55
TRAZODONE HCL 53 23 111 61
MONTELUKAST SODIUM 53 37 111 153
VENTOLIN HFA 53 18 111 101
KLOR-CON 8 52 40 114 260
OXYBUTYNIN CHLORIDE ER 52 52 114 85
HYDROXYZINE HCL 52 41 R 114 194
AMOX TR-POTASSIUM CLAVULANATE 51 45 117 131
LIPITOR 51 36 117 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.